927 related articles for article (PubMed ID: 19706786)
41. Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.
Assini JM; Mulvihill EE; Burke AC; Sutherland BG; Telford DE; Chhoker SS; Sawyez CG; Drangova M; Adams AC; Kharitonenkov A; Pin CL; Huff MW
Endocrinology; 2015 Jun; 156(6):2087-102. PubMed ID: 25774553
[TBL] [Abstract][Full Text] [Related]
42. Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice.
Weng Y; Chabot JR; Bernardo B; Yan Q; Zhu Y; Brenner MB; Vage C; Logan A; Calle R; Talukdar S
PLoS One; 2015; 10(3):e0119104. PubMed ID: 25790234
[TBL] [Abstract][Full Text] [Related]
43. Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance.
Zhang J; Wright W; Bernlohr DA; Cushman SW; Chen X
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1433-40. PubMed ID: 17244723
[TBL] [Abstract][Full Text] [Related]
44. Amylin stimulates fatty acid esterification in 3T3-L1 adipocytes.
Miegueu P; St-Pierre DH; Munkonda MN; Lapointe M; Cianflone K
Mol Cell Endocrinol; 2013 Feb; 366(1):99-107. PubMed ID: 23261986
[TBL] [Abstract][Full Text] [Related]
45. Downstream signaling pathways in mouse adipose tissues following acute in vivo administration of fibroblast growth factor 21.
Muise ES; Souza S; Chi A; Tan Y; Zhao X; Liu F; Dallas-Yang Q; Wu M; Sarr T; Zhu L; Guo H; Li Z; Li W; Hu W; Jiang G; Paweletz CP; Hendrickson RC; Thompson JR; Mu J; Berger JP; Mehmet H
PLoS One; 2013; 8(9):e73011. PubMed ID: 24039848
[TBL] [Abstract][Full Text] [Related]
46. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
[TBL] [Abstract][Full Text] [Related]
47. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state.
Fisher FM; Chui PC; Antonellis PJ; Bina HA; Kharitonenkov A; Flier JS; Maratos-Flier E
Diabetes; 2010 Nov; 59(11):2781-9. PubMed ID: 20682689
[TBL] [Abstract][Full Text] [Related]
48. CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice.
Parlevliet ET; Schröder-van der Elst JP; Corssmit EP; Picha K; O'Neil K; Stojanovic-Susulic V; Ort T; Havekes LM; Romijn JA; Pijl H
J Pharmacol Exp Ther; 2009 Jan; 328(1):240-8. PubMed ID: 18849357
[TBL] [Abstract][Full Text] [Related]
49. Pharmacological efficacy of FGF21 analogue, liraglutide and insulin glargine in treatment of type 2 diabetes.
Ye X; Qi J; Yu D; Wu Y; Zhu S; Li S; Wu Q; Ren G; Li D
J Diabetes Complications; 2017 Apr; 31(4):726-734. PubMed ID: 28143735
[TBL] [Abstract][Full Text] [Related]
50. An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice.
Holland WL; Adams AC; Brozinick JT; Bui HH; Miyauchi Y; Kusminski CM; Bauer SM; Wade M; Singhal E; Cheng CC; Volk K; Kuo MS; Gordillo R; Kharitonenkov A; Scherer PE
Cell Metab; 2013 May; 17(5):790-7. PubMed ID: 23663742
[TBL] [Abstract][Full Text] [Related]
51. FGF21 suppresses hepatic glucose production through the activation of atypical protein kinase Cι/λ.
Kong LJ; Feng W; Wright M; Chen Y; Dallas-yang Q; Zhou YP; Berger JP
Eur J Pharmacol; 2013 Feb; 702(1-3):302-8. PubMed ID: 23305840
[TBL] [Abstract][Full Text] [Related]
52. Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.
Hotta Y; Nakamura H; Konishi M; Murata Y; Takagi H; Matsumura S; Inoue K; Fushiki T; Itoh N
Endocrinology; 2009 Oct; 150(10):4625-33. PubMed ID: 19589869
[TBL] [Abstract][Full Text] [Related]
53. Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice.
Patel V; Joharapurkar A; Dhanesha N; Kshirsagar S; Patel K; Bahekar R; Shah G; Jain M
Can J Physiol Pharmacol; 2013 Dec; 91(12):1009-15. PubMed ID: 24289070
[TBL] [Abstract][Full Text] [Related]
54. Adipose hypothermia in obesity and its association with period homolog 1, insulin sensitivity, and inflammation in fat.
Yamaoka M; Maeda N; Takayama Y; Sekimoto R; Tsushima Y; Matsuda K; Mori T; Inoue K; Nishizawa H; Tominaga M; Funahashi T; Shimomura I
PLoS One; 2014; 9(11):e112813. PubMed ID: 25397888
[TBL] [Abstract][Full Text] [Related]
55. Long-term treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes.
Lagathu C; Yvan-Charvet L; Bastard JP; Maachi M; Quignard-Boulangé A; Capeau J; Caron M
Diabetologia; 2006 Sep; 49(9):2162-73. PubMed ID: 16865359
[TBL] [Abstract][Full Text] [Related]
56. Fibroblast growth factor 21 as an emerging metabolic regulator: clinical perspectives.
Woo YC; Xu A; Wang Y; Lam KS
Clin Endocrinol (Oxf); 2013 Apr; 78(4):489-96. PubMed ID: 23134073
[TBL] [Abstract][Full Text] [Related]
57. Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.
Li H; Bao Y; Xu A; Pan X; Lu J; Wu H; Lu H; Xiang K; Jia W
J Clin Endocrinol Metab; 2009 Jun; 94(6):2151-6. PubMed ID: 19318452
[TBL] [Abstract][Full Text] [Related]
58. Increased adipose tissue expression of Grb14 in several models of insulin resistance.
Cariou B; Capitaine N; Le Marcis V; Vega N; Béréziat V; Kergoat M; Laville M; Girard J; Vidal H; Burnol AF
FASEB J; 2004 Jun; 18(9):965-7. PubMed ID: 15059968
[TBL] [Abstract][Full Text] [Related]
59. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
[TBL] [Abstract][Full Text] [Related]
60. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding.
Markan KR; Naber MC; Ameka MK; Anderegg MD; Mangelsdorf DJ; Kliewer SA; Mohammadi M; Potthoff MJ
Diabetes; 2014 Dec; 63(12):4057-63. PubMed ID: 25008183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
